Molecular imaging and theranostics enhance oncologic management via integrated diagnostic and therapeutic modalities. Amid the dynamic and increasingly complex oncologic landscape, the Common Sense ...

Cite this: New Oncology Strategy: Molecular Targeting of Cancer Cells - Medscape - Jun 01, 2005. Abstract and Introduction Molecular Targets of Cancer Cells Under Investigation ...

Cancer metastasis—the spread of cancer to other organs—is the leading cause of death among cancer patients. Researchers have now uncovered a "genetic signature" of 177 genes shared across multiple ...

In a landmark study, researchers from Korea University have discovered a surprising answer: the protein WEE1, traditionally known as a cell cycle regulator and tumor suppressor, can paradoxically ...

Apart from testing for hereditary cancer syndromes, molecular testing is generally not recommended without clear evidence that the test result will affect clinical outcomes for the patient. 19 If ...

Molecular testing tools, including tumor sequencing and increasingly sensitive diagnostics, are leveling up oncology by enabling precise, personalized cancer treatment. Clinicians can now detect ...

Leaders of the Common Sense Oncology initiative, launched 1.5 years ago as “a new patient-centered movement in cancer care,” outline principles for trial design, analysis, and reporting.

New York City-based NYU Langone has named Shridar Ganesan, MD, PhD, as director of the Perlmutter Cancer Center’s new Center for Molecular Oncology. In collaboration with teams across NYU ...

Piloted at two Cancer Network sites, this PI/QI program aimed to optimize the use of molecular testing in thyroid and lung cancers. Activities in this program include: The Power of Precision ...